Dimethylsulfoxide (DMSO) treatment reduces infarction volume after permanent focal cerebral ischemia in rats

Neuroscience Letters

Volumn 239, Issue 2-3, 1997, Pages 125-127

  Shimizu, Shigetoshi ^a   Simon, Roger P ^a   Graham, Steven H ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cerebral ischemia; Dimethylsulfoxide

Indexed keywords

DIMETHYL SULFOXIDE; NEUROPROTECTIVE AGENT;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GAS ANALYSIS; BLOOD GLUCOSE; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DIMETHYL SULFOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN-ION CONCENTRATION; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031578763     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00915-4     Document Type: Article

References (22)

1. Andrus P.K., Taylor B.M., Sun F.F., Hall E.D. Effects of the lipid peroxidation inhibitor tirilazad mesylate (U-74006F) on gerbil brain eicosanoid levels following ischemia and reperfusion. Brain Res. 659:1994;126-132.
2. Ashwood-Smith M.J. Radioprotective and cryoprotective properties of dimethyl sulfoxide in cellular systems. Ann. N. Y. Acad. Sci. 141:1967;45-62.
3. Brown F.D., Johns L.M., Mullan S. Dimethyl sulfoxide in experimental brain injury, with comparison to mannitol. J. Neurosurg. 53:1980;58-62.
4. Chan P.H. Role of oxidants in ischemic brain damage. Stroke. 27:1996;1124-1129.
5. de la Torre J.C., Rowed D.W., Kawanaga H.M., Mullan S. Dimethyl sulfoxide in the treatment of experimental brain compression. J. Neurosurg. 38:1973;345-354.
6. de la Torre J.C., Surgeon J.W. Dexamethasone and DMSO in experimental transorbital cerebral infarction. Stroke. 7:1976;577-583.
7. Jacob S.W., Wood D.C. Dimethyl sulfoxide (DMSO). Toxicology, pharmacology, and clinical experience. Am. J. Surg. 114:1967;414-426.
8. James H.E., Camp P.E., Harbaugh R.D., Marshall L.F., Werner R. Comparison of the effects of DMSO and pentobarbitone on experimental brain oedema. Acta Neurochir. (Wien). 60:1982;245-255.
9. Karaca M., Bilgin U.Y., Akar M., de la Torre J.C. Dimethyl sulfoxide lowers ICP after closed head trauma. Eur. J. Clin. Pharmacol. 40:1991;113-114.
10. Klingman A.M. Topical pharmacology of dimethyl sulfoxide (DMSO). J. Am. Med. Assoc. 193:1965;796-802.
11. Kolb K.H., Jaenicke G., Kramer M., Schulze P.E. Absorption, distribution and elimination of labeled dimethyl sulfoxide in man and animals. Ann. N. Y. Acad. Sci. 141:1967;85-95.
12. Laha R.K., Dujovny M., Barrionuevo P.J., DeCastro S.C., Hellstrom H.R., Maroon J.C. Protective effects of methyl prednisolone and dimethyl sulfoxide in experimental middle cerebral artery embolectomy. J. Neurosurg. 49:1978;508-516.
13. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
14. Martz D., Rayos G., Schielke G.P., Betz A.L. Allopurinol and dimethylthiourea reduce brain infarction following middle cerebral artery occlusion in rats. Stroke. 20:1989;488-494.
15. McGraw C.P. The effect of dimethyl sulfoxide (DMSO) on cerebral infarction in the Mongolian gerbil. Acta Neurol. Scand. Suppl. 64:1977;160-161.
16. Rao C.V. Differential effects of detergents and dimethylsulfoxide on membrane prostaglandin E1 and F2 alpha receptors. Life Sci. 20:1977;2013-2022.
17. Shealy C.N. The physiological substrate of pain. Headache. 6:1966;101-108.
18. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., Sharp F.R. A semiautomated method for measuring brain infarct volume. J. Cerebral Blood Flow Metab. 10:1990;290-293.
19. Waller F.T., Tanabe C.T., Paxton H.D. Treatment of elevated intracranial pressure with dimethyl sulfoxide. Ann. N. Y. Acad. Sci. 411:1983;286-292.
20. Willis C.L., Meldrum B.S., Nunn P.B., Anderton B.H., Leigh P.N. Neuroprotective effect of free radical scavengers on beta-N-oxalylamino-L-alanine (BOAA)-induced neuronal damage in rat hippocampus. Neurosci. Lett. 182:1994;159-162.
21. Wood D.C., Wood J. Pharmacologic and biochemical considerations of dimethyl sulfoxide. Ann. N. Y. Acad. Sci. 243:1975;7-19.
22. Yang G., Chan P.H., Chen J., Carlson E., Chen S.F., Weinstein P., Epstein C.J., Kamii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 25:1994;165-170.